Scilligence Insights: Evolving our Software

At Scilligence, we have spent the last year exploring various avenues to enhance our scientific software. Using a three-pronged approach, we are committed to providing the tools necessary to optimize R&D workflows:

Partnerships for Expansion and Integration:

• Currently partnered with CAS, Certara 360, Chemical.ai, Tetrascience, and Zifo.
• Partnerships facilitate product expansion and integration by aligning business needs and workflows.

Features Development and Modality Enhancement:

• Constantly developing new features and improving existing ones based on user feedback.
• Unique capability to handle diverse modalities: small molecules, biologics, antibody drug conjugates, PROTACs, lipid nanoparticles, etc.
• Focus on improving capabilities and workflows for each modality.

Customer-Centric Focus and Researcher Workflow Improvements:

• Our strengths lie in a customer-centric approach, adapting and customizing to unique workflows.
• Emphasis on quality of life improvements to make daily software use a pleasurable and productive experience.
• Improvements to our roadmap process.

Key Features and Future Plans:

Version 7 Upgrade (October 2022):

• New look and enhanced UI/UX.
• Focused on functionalities for core products: Scilligence ELN, RegMol, and Inventory.

Version 7.2 (January 2024):

• Further UIUX enhancements : improvements to existing modalities, templates and privileges to enhance end-user experience.
• Streamlining of dataflow between Registration and Inventory Modules

Version 7.3 (Mid-2024) and beyond:

• Introduction of a complete lipid nanoparticle (LNP) workflow across Scilligence ELN, RegMol, and Inventory including LNP design in ELN and RegMol, registration, capturing assay data, capturing containers, and tracking stability
• Introduction of a formulations workflow across apps 
• Conjugation form improvements in ELN. Includes conjugate builder function to build conjugates with registered entities, relationship registration, , and simplified customization process
• Improvements in data capture flexibility using Microsoft Office in-place editing and reusable Flex forms.
• Introduction of new biologically focused capabilities to ELN, including sequence display and manipulation, blast search, and sequence alignment.
• Removal of XML layer for improved performance

As we embark on this journey of continuous improvement, Scilligence remains dedicated to providing solutions that streamline R&D processes, and drive innovation. 

Stay tuned for more updates!